← Back to Search
Behavioral Intervention
AI-Generated Summaries for Eye Disease
Los Angeles, CA
N/A
Recruiting
Led By Prashant Tailor, MD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age ≥ 18 years
English-speaking
Must not have
Unable to provide informed consent
Known cognitive impairments (e.g., dementia, intellectual disability) that would affect comprehension
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks post-visit
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if artificial intelligence-generated plain language summaries can help people better understand their eye doctor's notes. Participants at the Jules Stein Eye Institute will receive either regular medical notes or notes with an
See full description
Who is the study for?
This trial is for English-speaking adults who are receiving eye care at the Jules Stein Eye Institute. It's designed to help those who may struggle with understanding medical jargon, possibly including patients with aphasia or other communication difficulties.Check my eligibility
What is being tested?
The study is testing AI-generated summaries that translate ophthalmology notes into plain language. Participants will be randomly given either standard medical notes or ones with an AI summary, and their comprehension and confidence in care will be assessed through surveys and follow-up calls.See study design
What are the potential side effects?
Since this trial involves reading different types of medical summaries rather than a physical intervention, there are no direct side effects associated with the AI-generated plain language summaries.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
show original
Select...
I speak English.
show original
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am unable to understand and agree to the study details on my own.
show original
Select...
I do not have conditions like dementia that affect my understanding.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 weeks post-visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks post-visit
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Patient Comprehension Score (Immediate Post-Visit)
Secondary study objectives
Comprehension Gap Reduction
Error Rate for Ophthalmologist Overreads
Inbasket Message Rates
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SON + AI-Generated Plain Language SummariesExperimental Treatment1 Intervention
Participants in this arm receive the standard ophthalmology notes plus an AI-generated plain language summary, reviewed for accuracy before distribution. They will complete the same surveys to assess whether the additional summary improves their understanding and satisfaction compared to the control group.
Group II: Standard Ophthalmology Notes (SON) OnlyActive Control1 Intervention
Participants in this arm receive the standard ophthalmology notes typically provided after their clinic visit, with no additional plain language summary. They will complete surveys that measure their comprehension and satisfaction with the visit notes.
Find a Location
Closest Location:UCLA· Los Angeles, CA· 1976 miles
Who is running the clinical trial?
University of California, Los AngelesLead Sponsor
1,587 Previous Clinical Trials
10,422,228 Total Patients Enrolled
Prashant Tailor, MDPrincipal InvestigatorUniversity of California, Los Angeles